In contrast to effector CD4+ T cells (Th1, Th2, Th17, and Tfh) that activate other immune cells, Treg cells are inherently suppressive (48), and considered to have a detrimental role in cancer by suppressing the antitumor immune response. This evidence concerns the gene CD4 and cancer.